Objectives-To establish the incidence and severity of arterial oxygen desaturation during transoesophageal echocardiography performed under light intravenous sedation; to determine which patients are at greatest risk; and to assess the effects of supplementary oxygen treatment.
Transoesophageal echocardiography is now a widely practised procedure with a well established clinical value.' 2 Several reports have confirmed that the incidence of complications is low,' and these include specific studies of bacteraemia, endocarditis, ischaemia, and oesophageal trauma during or after transoesophageal echocardiography. 46 The incidence of hypoxaemia during transoesophageal echocardiography has not There was no difference in the dose of midazolam between the two groups. The mean (range) dose in patients without hypoxaemia was 3-7 (1l5-10-0) mg, and in the hypoxaemia group it was 3 2 (1 5-6 0) mg.
FACTORS ASSOCIATED WITH HYPOXAEMIA
The table shows that significant hypoxaemia during transoesphageal echocardiography was associated with NYHA classes III and IV; mitral valve disease including normal prosthetic mitral valves; and, especially, severe mitral regurgitation. Thus 23/27 (85%) of patients with hypoxaemia had mitral valve disease, of whom 15 had severe mitral regurgitation (3+ or 4+). The other eight patients had diagnoses including mitral stenosis or mixed mitral valve disease (three); or nonsevere mitral valve disease with infective endocarditis (two), with severe left ventricular dysfunction (two), and with aortic stenosis (one). The four patients with hypoxaemia but no mitral valve disease all had NYHA class III or IV symptoms. In addition two had severe left ventricular dysfunction, one had aortic valve endocarditis, and one had an atrial septal defect with puhnonary disease.
Discussion
Transoesophageal echocardiography is acknowledged to be a safe procedure with a very low complication rate. Reports concerning the morbidity and mortality of transoesophageal echocardiography have generally emphasised mechanical or anatomical problems.3 6Transcutaneous oximetry is not used routinely in many European centres. Thus the incidence and severity of hypoxaemia during transoesophageal echocardiography has not been previously assessed, and the potential for morbidity is unknown.
In this study of transoesophageal echocardiography performed under light sedation, we have shown that a minor degree of desaturation is almost universal, and significant hypoxaemia may occur in a sizable minority. Studies of arterial oxygen saturation during upper gastrointestinal endoscopy have shown that about half of the total fall in Sao, is caused by intravenous sedation alone, probably as a consequence of mild ventilatory depression. A further fall in Sao2 occurs during passage of the endoscope but this may be related to partial obstruction of the upper airway. 9 Our findings indicate that the patients at risk of hypoxaemia are principally those with mitral valve disease or prosthetic mitral valve dysfunction, and who have symptoms of NYHA class III or more. This is not surprising in view of the frequent presence of pulmonary vascular congestion and pulmonary hypertension in this group. Conversely, patients with diagnoses other than mitral valve disease seem to be at low risk unless left ventricular function is severely impaired, or pulmonary hypertension is present. A few patients may be sensitive even to small doses of benzodiazepines.
In this series, the procedure was complicated by considerable respiratory depression in two out of 150 patients (1.3%). This suggests that although significant hypoxaemia may occur in a sizable minority of patients, the incidence of related clinical morbidity is low.
Although many operators perform transoesophageal echocardiography on unsedated patients,3 10 light sedation may improve patient comfort and allow a longer, more detailed examination. The small additional risk associated with intravenous sedation is therefore acceptable provided arterial oxygen saturation is continuously monitored, and facilities for resuscitation, including oxygen, are available. As transoesophageal echocardiography is usually performed in darkened rooms, the early signs of hypoventilation and arterial desaturation would otherwise go unnoticed. Where necessary, oxygen rapidly reverses hypoxaemia, and routine oxygen treatment may largely prevent it.8 Routine monitoring of arterial oxygen saturation is a useful additional safety measure and we recommend that it be used routinely during transoesophageal echocardiography.
